Normal view MARC view ISBD view

Review: Stent fracture in the drug-eluting stent era. [Review]

MedStar author(s):

Citation: Cardiovascular Revascularization Medicine. 17(6):404-11, 2016 SepPMID: 27499060 Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewSubject headings: *Cardiovascular Agents/ad [Administration & Dosage] | *Drug-Eluting Stents | *Percutaneous Coronary Intervention/ae [Adverse Effects] | *Percutaneous Coronary Intervention/is [Instrumentation] | *Prosthesis Failure | Coronary Restenosis/et [Etiology] | Coronary Thrombosis/et [Etiology] | Humans | Prosthesis Design | Risk Factors | Treatment OutcomeYear: 2016 Local holdings: Available in print through MWHC library: 2002 - presentISSN:

1878-0938

Name of journal: Cardiovascular revascularization medicine : including molecular interventionsAbstract: Copyright © 2016 Elsevier Inc. All rights reserved.Stent fracture has been recognized as one cause of stent failure and has been associated with in-stent restenosis and stent thrombosis, even in 2nd-generation drug-eluting stents. Given the wide use of drug-eluting stents and paucity of contemporary data available concerning stent fracture, we reviewed clinical studies and the Food and Drug Administration's Manufacturer and User Device Experience (MAUDE) database to analyze the current trends, mechanisms, predictors, outcomes and treatment for stent fracture. All authors: Omar A, Ormiston JA, Pendyala LK, Waksman RFiscal year: FY2017Digital Object Identifier:

https://dx.doi.org/10.1016/j.carrev.2016.06.002

Date added to catalog: 2017-04-10

Holdings ( 1 )
Title notes ( 4 )

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode
Journal Article	MedStar Authors Catalog	Article	27499060	Available		27499060

Available in print through MWHC library: 2002 - present

Stent fracture has been recognized as one cause of stent failure and has been associated with in-stent restenosis and stent thrombosis, even in 2nd-generation drug-eluting stents. Given the wide use of drug-eluting stents and paucity of contemporary data available concerning stent fracture, we reviewed clinical studies and the Food and Drug Administration's Manufacturer and User Device Experience (MAUDE) database to analyze the current trends, mechanisms, predictors, outcomes and treatment for stent fracture.

English